BCPC Balchem
- 153.100
- -1.600-1.03%
Balchem News
Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo
Here's Why Balchem (NASDAQ:BCPC) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usu
Form 144 | Balchem(BCPC.US) Insider Proposes to Sell 383.95K in Common Stocks
SEC FILLINGS DISCLOSED/ May 24, $Balchem(BCPC.US)$ Insider Griffin Jonathan Harrison intends to sell 2,500 shares of its common stock on May 24, with a total market value of approximately $383.95K.
Form 144 | Balchem(BCPC.US) Insider Proposes to Sell 232.48K in Common Stocks
SEC FILLINGS DISCLOSED/ May 21, $Balchem(BCPC.US)$ Insider Griffin Jonathan Harrison intends to sell 1,500 shares of its common stock on May 21, with a total market value of approximately $232.48K.
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the Deuts
Insider Sale at Balchem Corp (BCPC): SVP & Chief Technology Officer Michael Sestrick Sells ...
Balchem(BCPC.US) Officer Sells US$297.93K in Common Stock
$Balchem(BCPC.US)$ Officer Sestrick Michael Robert sold 1,929 shares of common stock on May 10, 2024 at an average price of $154.4503 for a total value of $297.93K.Source: Announcement What is stateme
Balchem Insider Sold Shares Worth $297,935, According to a Recent SEC Filing
Michael Robert Sestrick, Senior Vice President & Chief Technology Officer, on May 10, 2024, sold 1,929 shares in Balchem (BCPC) for $297,935. Following the Form 4 filing with the SEC, Sestrick has con
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But the reality is that when a company lose
Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC)
Form 144 | Balchem(BCPC.US) Officer Proposes to Sell 297.93K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $Balchem(BCPC.US)$ Officer Sestrick Michael Robert intends to sell 1,929 shares of its common stock on May 10, with a total market value of approximately $297.93K. Se
Balchem(BCPC.US) Director Sells US$764.9K in Common Stock
$Balchem(BCPC.US)$ Director Fischer David B sold 5,000 shares of common stock on May 8, 2024 at an average price of $152.98 for a total value of $764.9K.Source: Announcement What is statement of chang
Form 144 | Balchem(BCPC.US) Director Proposes to Sell 766.4K in Common Stocks
SEC FILLINGS DISCLOSED/ May 8, $Balchem(BCPC.US)$ Director Fischer David B intends to sell 5,000 shares of its common stock on May 8, with a total market value of approximately $766.4K. Source: Ann
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Wedbush rai
Balchem Is Maintained at Buy by HC Wainwright & Co.
Balchem Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. : The Balchem (BCPC.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $167.00 to $170.00.
HC Wainwright & Co. : The Balchem (BCPC.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $167.00 to $170.00.
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $170
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $167 to $170.
Balchem Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 13.03% HC Wainwright & Co. $167 → $170 Maintains Buy 10/30/2023 -10.24% HC Wainwright & Co. $16
Buy Rating Affirmed for Balchem With Strong Q1 Performance and Positive Growth Outlook
Balchem First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Analysis
Price Target
No Data
